No modulation of postprandial metabolism by transcutaneous auricular vagus nerve stimulation: a cross-over study in 15 healthy men.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 19 03 2020
accepted: 29 10 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 23 3 2021
Statut: epublish

Résumé

Experimental evidence suggests a crucial role of the autonomic nervous system in whole body metabolism with major regulatory effects of the parasympathetic branch in postprandial adaptation. However, the relative contribution of this mechanism is still not fully clear in humans. We therefore compared the effects of transcutaneous auricular vagus nerve stimulation (taVNS, Cerbomed Nemos) with sham stimulation during an oral glucose tolerance test in a randomized, single-blind, cross-over design in 15 healthy lean men. Stimulation was performed for 150 min, 30 min before and during the entire oral glucose tolerance test with stimulation cycles of 30 s of on-phase and 30 s of off-phase and a 25 Hz impulse. Heart rate variability and plasma catecholamine levels were assessed as proxies of autonomic tone in the periphery. Neither analyzed heart rate variability parameters nor plasma catecholamine levels were significantly different between the two conditions. Plasma glucose, insulin sensitivity and insulin secretion were also comparable between conditions. Thus, the applied taVNS device or protocol was unable to achieve significant effects on autonomic innervation in peripheral organs. Accordingly, glucose metabolism remained unaltered. Therefore, alternative approaches are necessary to investigate the importance of the autonomic nervous system in postprandial human metabolism.

Identifiants

pubmed: 33235256
doi: 10.1038/s41598-020-77430-2
pii: 10.1038/s41598-020-77430-2
pmc: PMC7686306
doi:

Substances chimiques

Catecholamines 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20466

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Diabetes Care. 2000 Mar;23(3):295-301
pubmed: 10868854
Brain Stimul. 2020 Mar - Apr;13(2):470-473
pubmed: 31884186
Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):45-55
pubmed: 11270588
Acta Diabetol. 2016 Dec;53(6):1037-1044
pubmed: 27771766
Epilepsia. 2012 Jul;53(7):e115-8
pubmed: 22554199
Diabetes. 2001 May;50(5):1030-8
pubmed: 11334405
JPEN J Parenter Enteral Nutr. 2008 Sep-Oct;32(5):569-71
pubmed: 18753395
Brain Stimul. 2018 Jul - Aug;11(4):947-948
pubmed: 29895444
Rev Endocr Metab Disord. 2014 Mar;15(1):67-77
pubmed: 24174131
Horm Metab Res. 1993 Oct;25(10):507-12
pubmed: 8262457
J Neurosci. 2004 Nov 3;24(44):9985-92
pubmed: 15525784
Biomed Tech (Berl). 2008 Jun;53(3):104-11
pubmed: 18601618
Cell. 2018 Oct 18;175(3):665-678.e23
pubmed: 30245012
PLoS One. 2019 Oct 11;14(10):e0223848
pubmed: 31603939
Am J Physiol. 1992 Sep;263(3 Pt 2):R615-8
pubmed: 1357982
Brain Stimul. 2018 Jul - Aug;11(4):699-708
pubmed: 29716843
Diabet Med. 2003 May;20(5):399-405
pubmed: 12752490
J Anat. 2020 Apr;236(4):588-611
pubmed: 31742681
Behav Res Methods. 2011 Dec;43(4):1161-70
pubmed: 21573720
Mol Metab. 2018 Jan;7:71-79
pubmed: 29122559
BMC Complement Altern Med. 2014 Jun 26;14:203
pubmed: 24968966
Best Pract Res Clin Endocrinol Metab. 2003 Sep;17(3):305-22
pubmed: 12962688
Am J Clin Nutr. 2013 Apr;97(4):763-73
pubmed: 23446893
Brain Stimul. 2014 Nov-Dec;7(6):871-7
pubmed: 25164906
Adv Physiol Educ. 2013 Mar;37(1):53-60
pubmed: 23471249
Brain Stimul. 2015 May-Jun;8(3):624-36
pubmed: 25573069
Dig Dis Sci. 1999 Apr;44(4):857-61
pubmed: 10219849
Diabetes. 2014 Dec;63(12):4083-8
pubmed: 25028522
Neurogastroenterol Motil. 2008 May;20 Suppl 1:64-72
pubmed: 18402643
Acta Psychiatr Scand. 2016 Jan;133(1):44-52
pubmed: 26371411

Auteurs

Andreas Vosseler (A)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Dongxing Zhao (D)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.

Louise Fritsche (L)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Rainer Lehmann (R)

Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.

Konstantinos Kantartzis (K)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Dana M Small (DM)

Modern Diet and Physiology Research Center, Department of Psychiatry, Yale University, New Haven, CT, USA.

Andreas Peter (A)

German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.

Hans-Ulrich Häring (HU)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Andreas L Birkenfeld (AL)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Andreas Fritsche (A)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Robert Wagner (R)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Hubert Preißl (H)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Stephanie Kullmann (S)

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Martin Heni (M)

Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.
Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.
German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany. martin.heni@med.uni-tuebingen.de.
Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany. martin.heni@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH